Holly Davidson

Holly Davidson is an accomplished professional in the healthcare industry with extensive experience in access and reimbursement. Currently serving as Associate Director of Access and Reimbursement at TG Therapeutics, Inc. since October 2022, Holly has held significant roles at Genentech since July 2016, including Clinical Reimbursement Manager and Clinical Coordinator focusing on Multiple Sclerosis. Previously, at Teva Pharmaceuticals from August 2010 to July 2016, Holly worked as a Neuroimmunology Field Reimbursement Manager and Clinical Nurse Educator in the Neurology Division. Holly holds a Bachelor of Science degree in Nursing from The University of Tennessee at Chattanooga.